Methcarbamol
NDC Package 80175-0533-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Methcarbamol is methocarbamol tablets USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. Marketed by Central Packaging, this product is identified by NDC 80175-0533 and is authorized under FDA application ANDA090200.

Identification & Billing

NDC Package Code
80175-0533-9
Package Description
90 TABLET in 1 BOTTLE
Product Code
80175-0533
11-Digit Billing Format
80175053309
RxNorm Crosswalk
RxCUI: 197943 - methocarbamol 500 MG Oral Tablet

Clinical Specifications

Proprietary Name
Methcarbamol
Dosage Form
-
Usage Information
Methocarbamol tablets USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Regulatory & Marketing

Labeler Name
Central Packaging
FDA Application #
ANDA090200
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-20-2013
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 80175-0533-9 identifies a specific commercial package of 90 tablet in 1 bottle of Methcarbamol, labeled by Central Packaging. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Central Packaging on March 20, 2013. The current certification is valid through December 31, 2022.

How is this Central Packaging product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 80175053309. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
80175-0533-9
11-Digit CMS (5-4-2)
80175-0533-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.